BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22246385)

  • 1. Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival.
    Dun CA; Faber HT; de Wolf MJ; Mylanus EA; Cremers CW; Hol MK
    Otol Neurotol; 2012 Feb; 33(2):192-8. PubMed ID: 22246385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titanium fixtures for bone-conduction devices and the influence of type 2 diabetes mellitus.
    Horstink L; Faber HT; de Wolf MJ; Dun CA; Cremers CW; Hol MK
    Otol Neurotol; 2012 Aug; 33(6):1013-7. PubMed ID: 22722143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term complications of bone-anchored hearing aids: a 14-year experience.
    Badran K; Arya AK; Bunstone D; Mackinnon N
    J Laryngol Otol; 2009 Feb; 123(2):170-6. PubMed ID: 18492306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of a Percutaneous Wide-Diameter Bone-Anchored Hearing Implant: A Clinical Evaluation of More than 800 Implants.
    Teunissen EM; Caspers CJI; Vijverberg MA; Pennings RJE; Mylanus EAM; Hol MKS
    Otol Neurotol; 2024 Jun; 45(5):e435-e442. PubMed ID: 38728559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability, survival, and tolerability of a novel baha implant system: six-month data from a multicenter clinical investigation.
    Dun CA; de Wolf MJ; Hol MK; Wigren S; Eeg-Olofsson M; Green K; Karlsmo A; Flynn MC; Stalfors J; Rothera M; Mylanus EA; Cremers CW
    Otol Neurotol; 2011 Aug; 32(6):1001-7. PubMed ID: 21725257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant.
    Hol MK; Nelissen RC; Agterberg MJ; Cremers CW; Snik AF
    Otol Neurotol; 2013 Aug; 34(6):1071-5. PubMed ID: 23598702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraoral implants in the rehabilitation of craniofacial defects: implant and prosthesis survival rates and peri-implant soft tissue evaluation.
    Curi MM; Oliveira MF; Molina G; Cardoso CL; Oliveira Lde G; Branemark PI; Ribeiro Kde C
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1551-7. PubMed ID: 22698291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of osseointegrated bone conduction systems in children: a pilot study.
    Marsella P; Scorpecci A; D'Eredità R; Della Volpe A; Malerba P
    Otol Neurotol; 2012 Jul; 33(5):797-803. PubMed ID: 22643446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new Baha implant: a prospective osseointegration study.
    D'Eredità R; Caroncini M; Saetti R
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):979-83. PubMed ID: 22344291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Bone Conduction Implant Stability and Soft Tissue Status in Children in Relation to Age, Bone Thickness, and Sound Processor Loading Time.
    Mierzwiński J; Konopka W; Drela M; Łaz P; Śmiechura M; Strużycka M; Kuśmierczyk J
    Otol Neurotol; 2015 Aug; 36(7):1209-15. PubMed ID: 25569363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osseointegration timing for Baha system loading.
    Wazen JJ; Gupta R; Ghossaini S; Spitzer J; Farrugia M; Tjellstrom A
    Laryngoscope; 2007 May; 117(5):794-6. PubMed ID: 17473670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rates and periimplant soft tissue evaluation of extraoral implants over a mean follow-up period of three years.
    Karakoca S; Aydin C; Yilmaz H; Bal BT
    J Prosthet Dent; 2008 Dec; 100(6):458-64. PubMed ID: 19033030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loading of osseointegrated implants for bone conduction hearing at 3 weeks: 3-year stability, survival, and tolerability.
    Nelissen RC; den Besten CA; Faber HT; Dun CA; Mylanus EA; Hol MK
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1731-7. PubMed ID: 26272679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse skin reactions following percutaneous bone conduction implant surgery using the linear incision technique with and without subcutaneous tissue reduction.
    Van der Gucht K; Vanderveken O; Hamans E; Claes J; Van Rompaey V; Van de Heyning P
    Acta Otolaryngol; 2017 Feb; 137(2):149-153. PubMed ID: 27609549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-week loading of the 4.5mm wide titanium implant in bone anchored hearing systems.
    Wazen JJ; Babu S; Daugherty J; Metrailer A
    Am J Otolaryngol; 2016; 37(2):132-5. PubMed ID: 26954868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of stability measurements of the Baha® system in children.
    Felton M; Hill-Feltham P; Bruce IA
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):513-6. PubMed ID: 24467920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of the simplified surgical technique for BAHA implantation.
    de Wolf MJ; Hol MK; Huygen PL; Mylanus EA; Cremers CW
    Otol Neurotol; 2008 Dec; 29(8):1100-8. PubMed ID: 18800022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue overgrowth in bone-anchored hearing aid patients: use of 8.5 mm abutment.
    Pelosi S; Chandrasekhar SS
    J Laryngol Otol; 2011 Jun; 125(6):576-9. PubMed ID: 21457592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submerged or non-submerged healing of endosseous implants to be used in the rehabilitation of partially dentate patients.
    Cecchinato D; Olsson C; Lindhe J
    J Clin Periodontol; 2004 Apr; 31(4):299-308. PubMed ID: 15016259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three week loading for the Baha BI-300® implant system.
    Wazen JJ; Daugherty J; Darley S; Wycherly B
    Am J Otolaryngol; 2015; 36(2):195-9. PubMed ID: 25465654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.